Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m114.614891

Related search